Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy

RTTNews | vor 643 Tagen
Stocktwits
Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy

(RTTNews) - Pharmaceutical companies Astellas Pharma Inc. (ALPMY.PK) and Poseida Therapeutics, Inc. (PSTX) announced Monday a strategic investment to support the advancement of Poseida's commitment to redefining cancer cell therapy.

Under the terms of the transaction agreements, Astellas will invest a total of $50 million, including $25 million to acquire 8.3 million shares of common stock of Poseida or approximately 8.8% of the outstanding common stock of Poseida, at $3.00 per share in a private placement.

It will also make a one-time $25 million payment for a right of exclusive negotiation and first refusal to license one of Poseida's clinical stage programs: P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy in development for multiple solid tumor indications.

In addition, Poseida has granted Astellas a board observer seat, which includes the ability to attend Poseida's scientific advisory board meetings, and certain notice rights related to any potential change of control of Poseida.

Tags: ALPMY PSTX
Stocktwits
read more
Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

Astellas Pharma Inc. announced Friday the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of XTANDI (enzalutamide) as monotherapy or in combination with androgen deprivation therapy for the treatment of adult men with high risk biochemical recurrent (BCR) non-metastatic hormone sensitive prostate cancer (nmHSPC) who are unsuitable for salvage radiotherapy.
RTTNews | vor 415 Tagen
Japan Shares May Be Stuck In Neutral On Monday

Japan Shares May Be Stuck In Neutral On Monday

The Japanese stock market has moved higher in two straight sessions, rallying more than 720 points or 1.9 percent along the way. The Nikkei 225 now sits just above the 37,500-point plateau although the rally may stall on Monday.
RTTNews | vor 10 Minuten
KOSPI May Extend Friday's Losses

KOSPI May Extend Friday's Losses

The South Korea stock market on Friday ended the three-day winning streak in which it had risen more than 20 points or 0.8 percent. The KOSPI now sits just shy of the 2,580-point plateau and the losses may accelerate on Monday.
RTTNews | vor 40 Minuten
Japan Data On Tap For Monday

Japan Data On Tap For Monday

Japan is scheduled to see a few reports on Monday, highlighting a very light day for Asian-Pacific economic activity. On tap are current account figures for March and April numbers for bank lending and the Eco Watchers Survey.
RTTNews | vor 1Std 40 Minuten
U.S. Dollar Declines On Trade Deal Optimism

U.S. Dollar Declines On Trade Deal Optimism

The U.S. dollar weakened against its major counterparts in the New York session on Friday as investors looked ahead to discussions between the U.S. and China scheduled for this weekend.
RTTNews | vor 2 Tagen
Swiss Market Ends On Positive Note

Swiss Market Ends On Positive Note

The Swiss market closed higher on Friday as easing concerns about trade tensions following the announcement of a trade deal between the U.S. and U.K., and upcoming talks between U.S. and China helped keep the mood positive.
RTTNews | vor 2 Tagen
Tools
Wirtschaftskalender
Market Hours
Interest Rates
Holidays Calendar
Forex-Markt
Forex-Volatilität
Forex-Korrelation
Forex-Nachrichten
forex analysis
COT-Daten
Liquidität
Forex-Rechner
Forex Heat-Map
Indicators Heatmap
Community
Community
Systeme
Beliebteste Systeme
Strategien
Wettbewerbe
Forex-Charts
Forex-Sentiment
Prognoseindikator
Bewertungen
Broker
Prop Trading Firms
VPS-Dienste
Signalanbieter
EA Programmierdienstleistungen
Affiliate Programs
PAMM - Broker-Dienstleistungen
Rabattprogramm-Dienstleistungen
Handelsplattformen
Expertenberater
Krypto-Börsen
Trading Courses
Broker
Forex-Spreads
Forex-Broker-Kotierungen
Forex-Broker-Swaps
Volumen des Forex-Brokers
Forex-Broker-Aktionen Press Release
Plattform
Widgets
Funktionen
API
RSS
Stock Portfolio
Affiliate Software
Erweiterte Charts
Betreuung
FAQ
Hilfe
Kontaktieren Sie uns
Fehler melden!
Über uns
Blog
© 2025 Myfxbook Ltd. Alle Rechte vorbehalten.
WARNUNG VOR HOHEM RISIKO: Der Devisenhandel birgt ein hohes Risiko, das möglicherweise nicht für alle Anleger geeignet ist. Der Einsatz von Leverage schafft zusätzliches Risiko und Verlustgefahr. Bevor Sie sich für den Devisenhandel entscheiden, sollten Sie Ihre Anlageziele, Ihr Erfahrungsniveau und Ihre Risikotoleranz sorgfältig prüfen. Sie könnten Ihre ursprüngliche Investition teilweise oder ganz verlieren. Investieren Sie kein Geld, das Sie sich nicht leisten können, zu verlieren. Informieren Sie sich über die mit dem Devisenhandel verbundenen Risiken und lassen Sie sich von einem unabhängigen Finanz- oder Steuerberater beraten, wenn Sie Fragen haben. Alle Daten und Informationen werden ausschließlich zu Informationszwecken bereitgestellt und sind nicht für Handelszwecke oder Beratung gedacht. Die vergangene Performance ist kein Indikator für zukünftige Ergebnisse.